Search


Valo Health experts discuss how technology, data, and biology are converging to redefine how drug discovery and development are done
CSO Karin Conde-Knape and Chief Causal AI Officer Chris Anagnostopoulos discuss the difference between data collection in clinical trials and clinical care, and why they believe our industry has been underutilizing and sometimes misusing these data sets. They discusses the latest ways of harnessing technology to find targets that have a higher probability of clinical success. The Experts Karin Conde‑Knape, PhD is Senior Vice President and Chief Scientific Officer at Valo Heal
Sep 28


Brian Alexander, former CEO of Foundation Medicine, describes how Valo Health is using its AI expertise to partner with companies and foundations on discovery and development projects
The company recently received a grant from the Michael J. Fox Foundation to work on Parkinson's, and has existing partnerships with...
Oct 3, 2025






.png)